MDT

86.5

+0.42%↑

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

MDT

86.5

+0.42%↑

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

MDT

86.5

+0.42%↑

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

MDT

86.5

+0.42%↑

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

MDT

86.5

+0.42%↑

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

Home・Akcijų sąrašas・Pulse Biosciences Inc

Pulse Biosciences Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

23.03 0.57

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

22.92

Max

23.05

Pagrindiniai rodikliai
By Trading Economics
Pajamos	2M -17M
Pardavimai	178K 264K
Pelnas, tenkantis vienai akcijai	-0.257
Pelno marža	-6,603.409
Darbuotojai	116
EBITDA	2M -17M

Rekomendacijos
By TipRanks
Rekomendacijos	Pirkti
12 mėnesių prognozė	+30.43% upside

Dividendai
By Dow Jones
Kitas uždarbis	2026-05-07

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	-179M 958M
Ankstesnė atidarymo kaina	22.46
Ankstesnė uždarymo kaina	23.03

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Very Strong Bearish Evidence

16.59 / 17.17 Palaikymas ir pasipriešinimas

Pulse Biosciences Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-04-03 04:27; UTC

Svarbiausios naujienos

Singapore PM Warns That Fallout From Mideast War Could Outlast Conflict

2026-04-03 20:50; UTC

Rinkos pokalbiai

Tech, Media & Telecom Roundup: Market Talk

2026-04-03 18:30; UTC

Svarbiausios naujienos

An F15-E Just Went Down in Iran. What to Know About the $30 Million Jet. -- Barrons.com

2026-04-03 18:14; UTC

Rinkos pokalbiai

Eli Lilly Seen as Possible GLP-1 Leader With New Pill Approval -- Market Talk

2026-04-03 17:50; UTC

Rinkos pokalbiai

Microsoft's AI Development Will Weigh on Near-Term Azure Growth -- Market Talk

2026-04-03 17:44; UTC

Įsigijimai, susijungimai, perėmimai

SBA Stock Just Had a Big Day. Why It's Suddenly Hot. -- Barrons.com

2026-04-03 16:50; UTC

Svarbiausios naujienos

An F15-E Just Went Down in Iran. What to Know About the $90 Million Jet. -- Barrons.com

2026-04-03 16:20; UTC

Rinkos pokalbiai

Tech, Media & Telecom Roundup: Market Talk

2026-04-03 16:12; UTC

Uždarbis

Oil Stocks Look Tapped Out. Why It's Time to Move Into Other Sectors. -- Barrons.com

2026-04-03 15:56; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Crypto Markets May Be Active Over Holiday Weekend -- Market Talk

2026-04-03 15:56; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Global Equities Roundup: Market Talk

2026-04-03 15:56; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Global Forex and Fixed Income Roundup: Market Talk

2026-04-03 15:20; UTC

Svarbiausios naujienos

Berkshire, Travelers Join U.S. Plan to Insure Shippers in the Hormuz Strait -- Barrons.com

2026-04-03 15:08; UTC

Įsigijimai, susijungimai, perėmimai

OpenAI Makes Surprise Media Acquisition Ahead of IPO. Why It Will Fail. -- Barrons.com

2026-04-03 14:11; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Oil Shock From War in Iran May Show Up In 2Q Job Growth Data -- Market Talk

2026-04-03 12:56; UTC

Rinkos pokalbiai

Treasury Yields, Dollar Higher Following Robust March Hiring -- Market Talk

2026-04-03 08:20; UTC

Rinkos pokalbiai

Tech, Media & Telecom Roundup: Market Talk

2026-04-03 08:01; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2026-04-03 08:01; UTC

Rinkos pokalbiai

Meituan's Profitability Likely to Improve This Year -- Market Talk

2026-04-03 07:45; UTC

Rinkos pokalbiai

LG Electronics Could Post Above-Consensus 1Q Earnings -- Market Talk

2026-04-03 06:17; UTC

Rinkos pokalbiai

Naver Likely to Post Below-Consensus 1Q Earnings -- Market Talk

2026-04-03 06:17; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2026-04-03 04:33; UTC

Rinkos pokalbiai

China Merchants Port Earnings Likely to Recover This Year -- Market Talk

2026-04-03 04:33; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2026-04-03 04:15; UTC

Rinkos pokalbiai

Global Commodities Roundup: Market Talk

2026-04-03 04:01; UTC

Rinkos pokalbiai

Posco Holdings 1Q Earnings Could Fall Short of Expectations -- Market Talk

2026-04-03 02:01; UTC

Rinkos pokalbiai

India Consumer-Staple Companies Likely to Post Broadly Steady 4Q Results -- Market Talk

2026-04-03 01:59; UTC

Rinkos pokalbiai

Sea's Shopee E-Commerce Platform Likely in Reinvestment Phase -- Market Talk

2026-04-03 01:44; UTC

Rinkos pokalbiai

Samsung Likely to Report Record Quarterly Earnings in 2026 -- Market Talk

2026-04-03 01:22; UTC

Rinkos pokalbiai

Dollar Could Hit 160 Yen in Thin Holiday Trading -- Market Talk

Akcijų palyginimas

Kainos pokytis

Pulse Biosciences Inc Prognozė

Kainos tikslas

By TipRanks

30.43% į viršų

12 mėnesių prognozė

Vidutinis 30 USD 30.43%

Aukščiausias 30 USD

Žemiausias 30 USD

Remiantis 2 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Pulse Biosciences Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

2 ratings

Pirkti

Laikyti

Parduoti

Remiantis 2 analitikų, pateikusių Pulse Biosciences Inc akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Techninis įvertinimas

By Trading Central

16.59 / 17.17Palaikymas ir pasipriešinimas

Recent bearish events outweigh bullish events.

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę Pulse Biosciences Inc

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.